{"id":"W4283389183","doi":"10.1097/01.hs9.0000850912.43010.d3","title":"PB2020: MAJESTEC-3: RANDOMIZED, PHASE 3 STUDY OF TECLISTAMAB PLUS DARATUMUMAB VERSUS DPD OR DVD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Institute of Cancer Research","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Internal medicine; Pomalidomide; Oncology; Multiple myeloma; Bortezomib; Dexamethasone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004127428,0.0003729152,0.001215399,0.0002108611,0.0002382238,0.00001916007,0.0002393389,0.00008073249,0.002503184],"category_scores_gemma":[0.0006118084,0.0002599151,0.000151971,0.0007252203,0.0001533194,0.0001397792,0.000248765,0.0006319106,0.00003041787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006403865,"about_ca_system_score_gemma":0.0004334889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007190753,"about_ca_topic_score_gemma":0.001064816,"domain_scores_codex":[0.9962248,0.0004972573,0.000703737,0.0006175664,0.001387769,0.0005689154],"domain_scores_gemma":[0.9977758,0.0006861808,0.000287921,0.0007836007,0.0001825283,0.0002839543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8765176,0.01692872,0.09455125,0.0001594144,0.0007811508,0.00162696,0.001768393,0.0001001696,0.00004023509,0.00001045975,0.0004309941,0.007084667],"study_design_scores_gemma":[0.9414495,0.01840901,0.03135681,0.0001031759,0.0002649729,0.00001439341,0.006240982,0.0006990132,0.0001262419,0.000003440474,0.00105717,0.0002752425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922508,0.0003133556,0.00001270947,0.00004853965,0.0001958869,0.005219227,0.0001226066,0.00006786044,0.001769018],"genre_scores_gemma":[0.9965668,0.00001357736,0.0003943522,0.00002656164,0.00003627165,0.001002436,0.0002604688,0.00007451996,0.001625019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06493196,"threshold_uncertainty_score":0.9999853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02841387785979811,"score_gpt":0.3096109675587421,"score_spread":0.281197089698944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}